# NCT03391362 (NCT03391362)

> Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases

No report yet. It can be ordered.

- Drugs tested: none (the trial tests no drug)
- Indication: small cell lung cancer with 1-10 brain metastases

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03391362
- Phase: NA
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Brigham and Women's Hospital
- Conditions: Brain Metastases; Small Cell Lung Cancer
- Interventions: Stereotactic Radiation
- Enrollment: 100
- Primary outcome: Neurologic Mortality

## Indexed commentary on NCT03391362 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3
- YouTube: 1
- Podcasts: 1
- X videos: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct03391362